A novel role for zinc transporter 8 in the facilitation of zinc accumulation and regulation of testosterone synthesis in Leydig cells of human and mouse testicles

Metabolism ◽  
2018 ◽  
Vol 88 ◽  
pp. 40-50 ◽  
Author(s):  
Xiuli Zhang ◽  
Tingwen Guan ◽  
Boxuan Yang ◽  
Zhihong Chi ◽  
Zhan-You Wang ◽  
...  
2010 ◽  
Vol 95 (10) ◽  
pp. 4712-4719 ◽  
Author(s):  
J. M. Wenzlau ◽  
M. Walter ◽  
T. J. Gardner ◽  
L. M. Frisch ◽  
L. Yu ◽  
...  

2008 ◽  
Vol 79 ◽  
pp. S29-S30
Author(s):  
Yong Ho Lee ◽  
Eun Seok Kang ◽  
So Hun Kim ◽  
Seung JinHan ◽  
Kyu Yeon Hur ◽  
...  

2015 ◽  
Vol 447 ◽  
pp. 90-95 ◽  
Author(s):  
Gareth Dunseath ◽  
Rossitza Ananieva-Jordanova ◽  
Rebecca Coles ◽  
Michael Powell ◽  
Marie Amoroso ◽  
...  

Diabetologia ◽  
2019 ◽  
Vol 62 (11) ◽  
pp. 1969-1976 ◽  
Author(s):  
Claire L. Williams ◽  
Anna E. Long

2020 ◽  
Vol 84 (3) ◽  
pp. 112-124
Author(s):  
Lijia Zhao ◽  
Yaoyao Xiao ◽  
Cuimei Li ◽  
Jing Zhang ◽  
Yaojia Zhang ◽  
...  

2020 ◽  
Vol 6 (1) ◽  
pp. e30-e32
Author(s):  
Mimi Wong ◽  
Nirjhar Nandi ◽  
Ashim Sinha

Objective: Immunotherapy is a novel treatment that can cause autoimmune diabetes in rare cases. More cases occur following use of the inhibitor to the protein programmed cell death-1 rather than the inhibitor to programmed cell death-ligand 1. Methods: We report a unique case of autoimmune diabetes following atezolizumab use. Results: A 55-year-old, Aboriginal Australian female with no prior history of diabetes was commenced on atezolizumab for recurrent squamous cell lung carcinoma. Two months following its commencement, there was the onset of fatigue, polyuria, polydipsia, and new hyperglycemia. Subsequently she was found to have a borderline-low C peptide level of 0.6 nmol/L (reference range is 0.5 to 1.0 nmol/L), and positive zinc transporter-8 antibodies. Following the diagnosis of autoimmune diabetes, 5 units of glargine insulin was commenced which maintained euglycemia and resolved her symptoms of hyperglycemia. Conclusion: There are few case reports of atezolizumab-induced autoimmune diabetes. We present the first case associated with zinc transporter-8 antibodies, and a unique case of autoimmune diabetes in a patient of Aboriginal Australian background.


2019 ◽  
Vol 23 (5) ◽  
pp. 3140-3150 ◽  
Author(s):  
Chunxiao Yu ◽  
Fangjie Jiang ◽  
Meijie Zhang ◽  
Dandan Luo ◽  
Shanshan Shao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document